Penumbra (NYSE: PEN)
Penumbra Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Penumbra Company Info
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.
News & Analysis
Why Penumbra Stock Zoomed 4% Higher Today
The latest news from the lab, plus an analyst's bullish move, combined to put some zip in the company's shares.
Why Penumbra Stock Zoomed Nearly 5% Higher Today
The company might just be the right kind of business operating at the right time in history.
[FOR OLIVIA] This Medical Device Company Just Got a Big Boost
If you like good news and support from experts, this one's for you.
Why Penumbra Stock Sank Today
The company announced a product recall, prompting several analysts' downgrades.
Why Penumbra Stock Is Plunging Today
Investors are rattled by a short-seller's report.
Why Penumbra Stock Is Popping Today
The healthcare company posted better-than-expected Q3 results.
3 Highest Growth Stocks in the Market Today
Profit growth doesn't get any faster than this.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.